Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with colorectal adenocarcinoma (a specific type of bowel cancer), including those with inherited bowel cancer conditions such as Lynch syndrome, familial adenomatous polyposis, Peutz-Jeghers syndrome, juvenile polyposis syndrome, or serrated polyposis syndrome.
- People whose complete medical records and tissue sample (pathology) information are available at the trial centre.
- People whose colorectal cancer was diagnosed between 2013 and 2023.
Who may not be able to join:
- People whose colorectal cancer is a type other than adenocarcinoma.
- People whose cancer started in a nearby organ and spread into the colon or rectum.
- People whose cancer started in a distant organ and spread to the colon or rectum.
- People whose bowel condition is non-cancerous (benign).
- People whose colorectal cancer has come back after previous treatment (recurrent cancer).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
overall survival; DFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.